Helicobacter Pylori Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Tegoprazan-containing Sequential for H. Pylori
Conditions: Helicobacter Pylori Infection Interventions: Drug: Tegoprazan-containing sequential H. pylori eradication therapy Sponsors: Seoul National University Bundang Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2024 Category: Research Source Type: clinical trials

Prevalance Of Helicobacter Pylori Infection In Chonic Kidney Diseased Patient Admitted To Luxor Medical Complex
Conditions: Chronic Kidney Diseases Interventions: Other: disease Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials

Efficacy and Safety of Bismuth Quadruple Therapy Containing Cefuroxime and Tetracycline as First-line Therapy for Eradicating Helicobacter Pylori in Patients Allergic to Penicillin
Conditions: Helicobacter Pylori Infection Interventions: Drug: 14-day bismuth quadruple regimen containing cefuroxime and tetracycline; Drug: 14-day bismuth quadruple regimen containing cefuroxime and levofloxacin Sponsors: Qilu Hospital of Shandong University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2024 Category: Research Source Type: clinical trials

Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy, Vonoprazan-amoxicillin Dual Therapy and Proton Pump Inhibitor-based Standard Triple Therapy for Hp Eradication
Conditions: Helicobacter Pylori Eradication Interventions: Drug: vonoprazan, amoxicillin, tripotassium dicitrate bismuthate; Drug: vonoprazan, amoxicillin; Drug: rabeprazole, amoxicillin, clarithromycin Sponsors: Kaohsiung Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials

Efficacy and Safety of Tegoprazan Dual Therapy and Furazolidone-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication: A Prospective, Multicenter, Open-label, Randomized Controlled Clinical Study
Conditions: Helicobacter Pylori Infection; Tegoprazan; Furazolidone Interventions: Biological: Tegoprazan-amoxicillin dual therapy Sponsors: Nanjing First Hospital, Nanjing Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials

Banxiaxiexin Decoction Combined With Vonoprazan-Amoxicillin Dual Therapy in H.Pylori Eradication
Conditions: Helicobacter Pylori Infection Interventions: Drug: Vonoprazan; Drug: Amoxicillin; Drug: Banxiaxiexin decotion Sponsors: Nanjing First Hospital, Nanjing Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials

A Phase 1 Clinical Trial to Evaluate the Safety and Tolerability, Pharmacokinetics of Multiple Administrations of TNP-2092 Capsules in Combination With Rabeprazole Sodium Enteric-coated Tablets
Conditions: Helicobacter Pylori Infection Interventions: Drug: TNP-2092; Drug: TNP-2092 capsules placebo Sponsors: TenNor Therapeutics Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials

The Safety and Tolerability, Pharmacokinetics of TNP-2092 Capsules in Combination With Rabeprazole Sodium Enteric-coated Tablets
Conditions: Helicobacter Pylori Infection Interventions: Drug: TNP-2092 capsules; Drug: TNP-2092 capsules placebo; Drug: Rabeprazole sodium enteric-coated tablets Sponsors: TenNor Therapeutics Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials

Minocycline for Helicobacter Pylori Rescue Treatment
Conditions: Helicobacter Pylori Infection Interventions: Drug: BQT; Drug: EBM4M4; Drug: EBM3M3; Drug: EBM2M4; Drug: EBM2M3 Sponsors: Shanghai Jiao Tong University School of Medicine Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2024 Category: Research Source Type: clinical trials

Efficacy and Safety of a Triple Eradication Scheme for Helicobacter Pylori Based on Tegoprazan vs Esomeprazole
Conditions: Helicobacter Pylori Infection Interventions: Drug: Tegoprazan; Drug: Esomeprazole 40mg Sponsors: Hospital General de M éxico Dr. Eduardo Liceaga Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2024 Category: Research Source Type: clinical trials

Safety and Efficacy of Triple and Quadruple Regimens as First Line Therapy for Management of Helicobacter Pylori Infection in Egyptians
Conditions: H.Pylori Infection Interventions: Drug: Omeprazole 20 MG Oral Tablet; Drug: Amoxicillin 500Mg Tab; Drug: Clarithromycin 500Mg Tab Sponsors: Helwan University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials

Clinical Efficacy and Safety Assessment of Alsareen Capsule for the Management of H. Pylori Infection
Conditions: H. Pylori Infection Sponsors: Hamdard University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials

Pepsinogen II and Helicobacter Pylori Test in Gastric Cancer
Conditions: Gastric Cancer Sponsors: Seoul National University Bundang Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials

Triple Versus Quadruple Therapy for the Eradication of Helicobacter Pylori
Conditions: Helicobacter Pylori Infection Interventions: Drug: Vonoprazan-Amoxicillin-Tetracycline-Bismuth quadruple regimen for 14 days; Drug: Vonoprazan-Amoxicillin-Tetracycline triple regimen for 14 days; Drug: Vonoprazan-Amoxicillin-Tetracycline triple regimen for 7 days Sponsors: Shandong University; Binzhou Maternal and Child Health Hospital; Zibo Maternal and Child Health Hospital; Zaozhuang Municipal Hospital; Linyi Yizhou Hospital; Feicheng Municipal People ' s Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials

Effect of Intestinal Microecology After HDDT Combined With Probiotics for Helicobacter Pylori Eradication
Conditions: H Pylori Infection Eradication Interventions: Drug: Vonorason; Drug: Amoxicillin; Drug: Bacillus subtilis enteric-coated capsules Sponsors: Zhongshan Hospital (Xiamen), Fudan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2024 Category: Research Source Type: clinical trials